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Summary
HIV/SIV envelope glycoproteins mediate the first
steps in viral infection. They are trimers of a membrane-
anchored polypeptide chain, cleaved into two frag-
ments known as gp120 and gp41. The structure of HIV
gp120 bound with receptor (CD4) has been known for
some time. We have now determined the structure of
a fully glycosylated SIV gp120 envelope glycoprotein
in an unliganded conformation by X-ray crystallogra-
phy at 4.0 Å resolution. We describe here our experi-
mental and computational approaches, which may be
relevant to other resolution-limited crystallographic
problems. Key issues were attention to details of beam
geometry mandated by small, weakly diffracting crys-
tals, and choice of strategies for phase improvement,
starting with two isomorphous derivatives and includ-
ing multicrystal averaging. We validated the structure
by analyzing composite omit maps, averaged among
three distinct crystal lattices, and by calculating model-
based, SeMet anomalous difference maps. There are at
least four ordered sugars on many of the thirteen oli-
gosaccharides.
Introduction
The envelope glycoproteins of the primate immunodefi-
ciency viruses (HIV and SIV) mediate attachment to a
host cell and fusion of viral and host cell membranes.
They project from the surface of the virion, and they
induce both neutralizing and nonneutralizing antibodies
(Burton et al., 2004; Wyatt et al., 1998). They are also the
target of fusion inhibitors, exemplified by T-20/Enfuvir-
tide (Kilby and Eron, 2003; Wild et al., 1994), and of some
more recently studied attachment inhibitors (Lin et al.,
2003; Wang et al., 2003). The envelope glycoprotein is
synthesized as a precursor (gp160), which oligomerizes
and is subsequently cleaved into the receptor binding
subunit, gp120, and the transmembrane and fusion
subunit, gp41 (Allan et al., 1985; Veronese et al., 1985).*Correspondence: harrison@crystal.harvard.edu
4 DeceasedCleavage is necessary for activating the fusion-promot-
ing capacity.
Sequences of gp120 from different immunodeficiency
viruses show five relatively conserved regions (C1–C5)
and five variable regions (V1–V5) (Starcich et al., 1986)
(Figure 1A). The flexibility and variability of the protein
surface, resulting from both heavy glycosylation and
variable polypeptide-chain loops, are believed to have
evolved to evade the host immune response (Wei et al.,
2003). On mature virions, the gp120/gp41 complex is a
noncovalently linked trimeric spike (Center et al., 2001,
2002). Gp120 binds sequentially to the viral receptor
and coreceptor on the surface of host cells (CD4 and a
chemokine receptor, respectively), and in response to
these interactions undergoes conformational changes
that initiate the fusion process and lead to its dissoci-
ation from the trimer (Dalgleish et al., 1984; Feng et al.,
1996; Moore et al., 1990; Sattentau and Moore, 1991;
Sattentau et al., 1993; Trkola et al., 1996; Wu et al.,
1996). The N-terminal fusion peptide of gp41 is then
available to insert into the target cell membrane, fol-
lowed by further large conformational changes that
bring the two membranes together (Chan et al., 1997;
Weissenhorn et al., 1997, 1999).
The structure of the gp120 “core” (gp120 stripped of
N- and C-terminal extensions, V1–V2, and V3: see Fig-
ure 1 for definition), bound with CD4 and the Fab of
mAb 17b, has been determined for two different HIV-1
isolates (Kwong et al., 1998, 2000). The site on gp120
for mAb 17b includes residues that determine the core-
ceptor interaction, and the antibody footprint is thought
to mark the coreceptor site (Rizzuto et al., 1998). Thus,
the structure probably represents the released form of
gp120. The gp120 core folds into two closely associ-
ated domains, termed “inner” and “outer” (Kwong et
al., 1998). The base of the V1–V2 variable region (the
“V1–V2 stem”), in the inner domain, and a β-hairpin that
projects from the outer domain form a four-strand
“bridging sheet,” which fixes the relative orientations of
the two domains (Kwong et al., 1998). This sheet con-
tributes to binding of both CD4 and mAb 17b, and it
probably contains many or most of the residues critical
for coreceptor interaction (Rizzuto and Sodroski, 2000;
Rizzuto et al., 1998).
Carbohydrates of glycoproteins are a major source
of surface flexibility, and glycoproteins with a large
number of glycans are difficult to crystallize in their fully
glycosylated form. We have determined the structure
of a fully glycosylated SIV gp120 envelope glycoprotein
in an unliganded conformation by X-ray crystallography
at 4.0 Å resolution. Crystals of SIV gp120 diffract quite
weakly, presumably due to heavy glycosylation and
small crystal size. The low-resolution of our data and
the lack of noncrystallographic symmetry posed con-
siderable challenges for the structure determination.
We describe here solutions to some of the experimental
and computational difficulties, as our experience in de-
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198Figure 1. SIV Envelope Glycoproteins and
Production of SIV gp120 Core Protein
(A) Schematic representations of SIV enve-
lope glycoproteins: gp160, the full-length
precursor; gp140, the uncleaved ectodomain
of gp160; gp120, the surface subunit; and
gp120 core, the truncated protein used for
crystallographic studies. Glycans are repre-
sented by tree-like symbols. Various seg-
ments of gp120 and gp41 are designated as
follows: C1–C5, conserved regions 1–5; V1–
V5, variable regions 1–5; F, fusion peptide;
HR1, heptad repeats 1; HR2, heptad repeats
2; TM, transmembrane segment.
(B) SIV gp120 core protein was purified by
mAb 17A11 affinity chromatography from su-
pernatants of insect cell culture, and then re-
solved by gel-filtration chromatography using
a Superdex 200 column. Molecular weights
were calculated based on a standard curve
plotted using known proteins. Peak fractions
were pooled and analyzed by SDS-PAGE
(inset).termining the structure of this heavily glycosylated pro- a
tein may be useful for work on other crystallographic g
problems with limited resolution and poor initial phase c
information. Recording data adequate for structure h
analysis required optimal conditions at a synchrotron V
source. Initial experimental phases were gradually im- i
proved by iterative phase combination, data sharpen- n
ing, density modification, multicrystal averaging, and g
model building. Most of the thirteen oligosaccharides p
have at least four well-ordered sugars. They cluster into s
networks, in some cases extending to decorate the n
protein surface of crystallographically related mole- 1
cules. S
u
gResults
s
pExpression and Purification of SIV gp120 Core
6Protein from Insect Cells
iThe surface flexibility of HIV/SIV envelope glycopro-
iteins, due both to heavy glycosylation and surface-ex-
dposed variable loops (V1–V5; Figure 1A), has been a
Eprincipal obstacle to crystallographic studies (Kwong
et al., 1999). To produce an SIV gp120 protein suitable
for X-ray crystallographic analysis, we have deleted 43 gnd 22 residues from the N- and C- termini of SIV
p120, respectively, following work on the HIV-1 gp120
ore (Kwong et al., 1999; Wyatt et al., 1993), and we
ave substituted short linkers (GAG) for the V1-V2 and
3 loops (Figure 1A). Two extra residues (His-Met) were
ntroduced by the restriction site (Nde I) at the N termi-
us. We designate this protein, which still retains 13
lycosylation sites, the SIV gp120 core protein. It was
roduced in insect cells using a baculovirus expression
ystem and purified from cell supernatants by immu-
oaffinity chromatography using monoclonal antibody
7A11 (Edinger et al., 2000), followed by gel filtration.
IV gp120 core protein elutes from a Superdex 200 col-
mn as a sharp peak, which corresponds to a 60 kDa
lobular protein (Figure 1B). Analysis by SDS-PAGE
howed that it migrates as a single, somewhat diffuse
rotein band, also with an apparent molecular mass of
0 kDa. The calculated mass of the polypeptide chain
s about 39 kDa. The larger apparent size of the protein
s due to heavy glycosylation, as indicated by the re-
uced size of the protein when treated with PNGase F,
ndo F, or Endo H (data not shown).
We also prepared selenomethionine-substituted SIV
p120 core protein in order to obtain additional experi-
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199mental phase information, following the protocol de-
scribed in Experimental Procedures.
Crystallization of the Fully Glycosylated SIV gp120
Core Protein
Initial attempts to crystallize SIV gp120 core protein
were carried out using simple grid screens (concentra-
tion of precipitants versus pH) with polyethylene glycol
4000 or ammonium sulfate as precipitants. Some first
hints of crystals appeared in hanging drops in which
the protein had been mixed, at 1:1 ratio, with a mother
liquor containing 15% polyethylene glycol 4000 and
100 mM sodium citrate, (pH 5). Fine-tuning of the crys-
tallization conditions produced roundish crystals (Fig-
ure 2A), which grew to about 150 microns in the largest
dimension in 2–3 weeks, but which yielded only a few
reflections at very low (15 Å) resolution. We used addi-
tive screens (Hampton Research) to identify polyethyl-
ene glycol (PEG) 400 as useful, and we subsequently
obtained tetragonal crystals by including 8% PEG 400
in the crystallization solution (Figure 2B). These crystals
gave measurable diffraction to 4.0 Å at a synchrotron
source (see below). Analysis of washed crystals by
SDS-PAGE confirmed that they contained SIV gp120
core protein with no apparent degradation during the
crystallization process (Figure 2E, lane 9).
Further attempts to improve crystalline order in-
cluded varying the size of the polyethylene glycol pre-
cipitant (PEG 6000 gave slightly larger crystals than
smaller or larger PEGs), the buffer, and other parame-
ters. When 100 mM sodium acetate, (pH 5), was used
instead of sodium citrate, elongated crystals appeared
(Figure 2C), but these apparently trigonal crystals gave
diffraction to spacings no better than 15 Å, even at the
brightest synchrotron beamlines. Deglycosylation with
PNGase F or Endo F prevented crystallization under all
conditions examined. Use of Endo H, which yields only
partial deglycosylation, produced gp120 core protein
that crystallized from 2 M ammonium sulfate, (pH 6)
(Figure 2D), but the crystals diffracted only to spacings
of about 10 Å even when using crystals that grew to
100 microns in the longest dimension. In the case of
HIV gp120 core protein, deglycosylation was essential
for obtaining satisfactory crystals (Kwong et al., 1999),
but this observation is evidently not a general rule. We
also attempted to crystallize a number of complexes
with Fab fragments, derived from mAbs 2C3, 2C9,
17A11, 3E9, 4E11, 11F2, 7D3, 8C7, and 5B11 (Edinger
et al., 2000; Kim et al., 2001). None gave crystals suit-
able for diffraction experiments.
Diffraction Measurements
The SIV gp120 core protein crystals diffract very
weakly, even allowing for their relatively small size. Of
the several crystal forms we have obtained, the tetrago-
nal crystals (Figure 2B) have yielded the best diffraction
data. We could detect no diffraction from these crystals
using a laboratory X-ray source, however, and long ex-
posure times were required at synchrotron sources. All
diffraction data were collected at CHESS beamline F1
and APS beamline 19ID. Optimization of crystal freez-
ing conditions and beamline setup at the synchrotron
allowed us to observe reflections to spacings of about3.8 Å (Figure 3). We found 15% sucrose to be the best
cryoprotectant. Dehydration by gradually increasing
the PEG concentration did not improve the order, nor
did annealing in the cryostream. A small beamstop
(about 1 mm diameter) placed very close the crystal
(about 1 cm) and a large crystal-to-detector distance
(400 mm) were both essential for reducing background
sufficiently to detect reflections beyond 4.5 Å. One of
our best crystals gave weak diffraction with few over-
loads even after 3 min of exposure at CHESS F1 (Figure
3A), but the high-resolution reflections gradually faded
into diffuse scattering in the water ring, suggesting that
the crystals may be ordered to beyond 3.8 Å. Use of
smaller nylon loops for freezing, to reduce the amount
of solvent surrounding the crystal, did not decrease the
water-ring intensity sufficiently to allow us to push the
resolution beyond it. Our best data set for native crys-
tals (for which we chose a 4.0 Å resolution cutoff based
on a S/N ratio of 1.3, Bc44n in Table 1) was collected
at CHESS F1. Data collected at APS 19ID were compa-
rable to those from CHESS, despite the much brighter
beam, because it was not possible to take further steps
to reduce the relative strength of the water ring. The
programs Denzo and Scalepack were used for integ-
rating and scaling the data (Otwinowski and Minor,
1997). The crystals belong to space group P43212 (a =
b = 108.1 Å, c = 117.7 Å), with one molecule per crystal-
lographic asymmetric unit and 60% solvent content.
Initial Phase Determination and Phase Improvement
Attempts to determine the structure by molecular re-
placement using various search models derived from
the HIV gp120 core structure were unsuccessful. We
screened (at CHESS F1) hundreds of crystals soaked
with over 60 heavy atom compounds for isomorphous
heavy-atom derivatives. Crystals soaked with either
K2IrCl6 (Ibc1 and Sbc10L in Table1; Cbc4 in Figure 3B)
or trimethyl lead acetate (TMLA) (Ibc44 in Table1) were
isomorphous to unsoaked crystals and produced data
sets from which heavy atom binding sites could be de-
termined. One Ir site could be identified independently
from isomorphous differences and anomalous differ-
ences (the wavelength at CHESS F1 was 0.916 Å, nearly
optimal for single-wavelength anomalous dispersion
from the LI edge of Ir), using the program SOLVE (Terwil-
liger and Berendzen, 1999). One Pb site was found by
difference Fourier analysis using phases calculated
from the K2IrCl6 derivative (Cbc4). The Ir and Pb sites
were crossvalidated using difference Fouriers. A third
derivative could be produced by soaking crystals with
IrCl3 (Hbc7 in Table 1); those crystals suffered from sig-
nificant nonisomorphism (cell constants a = b = 107.1
Å and c = 119.6 Å), and their contribution to the MIR
phases was small due to the Ir site shared with the
K2IrCl6 derivative (Ibc1 or Cbc4). When crystals were
soaked with cadmium iodide, cell constants changed
significantly (a = b = 110.9 Å and c = 111.9 Å); data
collected from these crystals were quite useful for
multicrystal averaging at a later stage (Hbc2/3 in Table
1; see below). We also obtained small SeMet-substi-
tuted crystals (about 70 microns in the largest dimen-
sion). The best data set (to about 4.7 Å resolution; Sb38
in Table 1) for SeMet crystals at the peak wavelength
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The fully glycosylated SIV gp120 core protein crystallized in hanging or sitting drops under various conditions, with mother liquor containing
15% PEG 4000, 100 mM sodium citrate, pH 5.5 at 20°C (A); 15% PEG 6000, 100 mM sodium citrate, (pH 5.0), 8% PEG 400 at 20°C (B); 15%
PEG 6000, 100 mM sodium acetate, (pH 5.0), 8% PEG 400 at 20°C (C); the protein deglycosylated by Endo H with mother liquor containing 2
M ammonium sulfate, 100 mM MES, pH 6.0 at 18°C (D).
(E) Three crystals of about 100 microns from (B) were carefully washed 6 times with mother liquor and then dissolved in SDS-loading buffer.
The sample (lane 9) was then analyzed along with the drop (lane 2) and 6 washes (lanes 3 to 8) by SDS-PAGE.(0.97935 Å) was obtained at APS 19ID. Eight selenium H
asites were subsequently identified by anomalous differ-
ence Fourier analysis using phases combined from the n
tK2IrCl6, IrCl3, and TMLA derivatives.
We refined the heavy-atom sites from all four deriva- 4
etives together using the program SHARP (de la Fortelle
and Bricogne, 1997). The resulting electron density 4
amap after density modification (using SHARP) allowed
us to fit a partial model of the outer domain from the cIV gp120 core (Kwong et al., 1998). The long α-helix
nd a surrounding β sheet of the outer domain matched
icely with the map, as shown in Figure 4A. In addition,
his fit placed each of Met 308, Met 356, Met 390, Met
02, and Met 481 in the vicinity of one selenium site
ach. The three sites that correspond to Met 390, Met
02, and Met 481 were too close to each other to be
ssigned definitively at the time, but the agreement
learly validated our initial experimental phases. Strong
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201Figure 3. Diffraction from SIV gp120 Core
Protein Crystals
(A) A diffraction image was recorded at CHESS
beamline F1 using an ADSC Quantum-4 CCD
detector with one of our best tetragonal
crystals soaked with 1 mM K2IrCl6. A beam
stop of 1 mm diameter, a large crystal-to-de-
tector distance (at least 400 cm) and a long
exposure time (3 min) were required to
increase the signal-to-noise ratio. Reflec-
tions at 3.8 Å are clearly visible, but reflec-
tions at higher resolution fade into the dif-
fuse scatter of the water ring.
(B) Inset table, crystallographic statistics of
the complete data set from the crystal dis-
cussed in (A).features branching out from the polypeptide-chain den-
sity at several glycosylation sites provided further evi-
dence for our initial fit.
Model Building and Refinement
Even from the electron density map calculated with ex-
perimental phases, we could see that the inner domain
of unliganded SIV gp120 differs greatly from that of CD4
bound HIV gp120. We therefore focused our initial ef-
forts on building the outer domain as accurately as
possible, guided by the HIV model, in order to improve
the phases. We took a polyalanine model of the portion
of the HIV outer domain that fit the density well and
used it as a starting point. Experimental data fall offsharply with increasing resolution (Figure 4B), and side
chain density was apparent only after data were sharp-
ened by applying a B factor of –200 to the amplitudes.
Sequence registration was determined by alignment
with the HIV model, selenium sites, and glycosylation
sites. We used iterative cycles of phase combination
(partial model phases and experimental phases), den-
sity modification, data sharpening, model building, and
limited model refinement to improve and extend the ini-
tial model. After we had built about 70% of the struc-
ture, including some of the inner domain, the model
was placed, by both rigid body refinement and molecu-
lar replacement, into the three crystal lattices available
for multicrystal averaging: native (Bc44n), IrCl3-soaked
Structure
202Table 1. Data Collection, Phasing, and Refinement Statistics
Data Set Bc44n Ibc1 Sbc10L Sb38 Ibc44 Hbc7 Hbc2/3
Compound Native K2IrCl6 K2IrCl6 SeMet TMLA IrCl3 CdI2
Resolution limits (Å) 25.6 to 4.00 18.6 to 4.25 48.8 to 7.00 39.8 to 4.70 18.6 to 4.77 16.7 to 4.29 18.5 to 4.22
Cell constants (Å/°) a = b = 108.05, a = b = 107.43, a = b = 106.90, a = b = 107.49, a = b = 109.40, a = b = 106.95, a = b = 110.86,
c = 117.70 c = 118.14 c = 117.84 c = 118.21 c = 117.74 c = 119.55 c = 111.87
α = β = γ = 90.0 α = β = γ = 90.0 α = β = γ = 90.0 α = β = γ = 90.0 α = β = γ = 90.0 α = β = γ = 90.0 α = β = γ = 90.0
Mosaicity (°) 0.35 0.57 0.58 0.58 0.31 0.47 0.79
Measured reflections 100402 186459 20576 108316 73691 56384 39052
Unique reflections 6216 5132 1076 3859 3699 4367 4548
Mean I/σ(I) 12.0 (1.3) 15.4 (5.5) 15.5 (5.9) 13.3 (1.9) 10.9 (4.3) 9.6 (3.4) 5.7 (1.7)
Rsymm (%) 8.3 (81.7) 11.8 (43.5) 9.0 (28.4) 10.6 (85.5) 10.0 (46.5) 12.1 (45.0) 13.3 (40.9)
Completeness (%) 98.0 (94.3) 97.4 (100.0) 87.3 (88.4) 98.2 (100.0) 95.2 (96.8) 85.3 (90.0) 84.1 (72.6)
Redundancy 4.5 13.8 7.1 6.8 6.7 6.4 2.9
Phasing
Sites 2 2 7 2 1
Rmerge 0.169 0.205 0.110 0.177 0.463
RCullis (iso/ano) 0.746/0.926 0.878/0.874 1.080/0.956 0.888/1.000 0.894/0.916
Phasing power (iso/ano) 0.763/0.618 0.617/0.966 0.296/0.357 0.161/0.109 0.418/0.595
FOM 0.25/0.32
Refinement
Residues built 304 (316) B-Factor values Ramachandran plot statistics
Sugars built 50
Rfree reflections 300 (5%) <model B> 128.8 Most favoured regions 62.1% (167)
FOM 0.642 Patterson B 101.2 Generously allowed regions 5.9% (16)
Bond lenghts (Å) 0.014/2.067 Disallowed regions 2.2% (6)
/angles (°) rmsd
All data were collected at λ=0.916 Å at beamline CHESS F1, except data set SB38 which was collected at λ = 0.97935 Å at beamline APS 19ID.
Rsymm = Σ(|I-I|) / Σ(I) where I is the observed reflection intensity.
Rmerge = Σ(|Fph - Fp|) / Σ(Fp) where Fp and Fph are the observed native and derivative structure factors, respectively.
RCullis = Σ|(|Fph|±|Fp|) - |Fh|| / Σ||Fph| - |Fp|| where Fp and Fph are the observed native and derivative structure factors, respectively, and Fh is the (calculated)heavy-atom
structure factor.
Phasing power = Fh / E where Fh is the (calculated) heavy-atom structure factor and E is the phase-integrated lack-of-closure.
Rcryst = Σ(||Fobs| - |Fcalc||) / Σ(|Fobs|) where Fobs (which equals Fp) is the observed native structure factor and Fcalc is the structure factor calculated from the model.(Hbc7), and CdI-soaked (Hbc2/3) crystals. Both rigid- s
abody refinement and molecular replacement gave the
same results, indicating that there was little global shift b
cof the model in any of the lattices. We determined
transformation matrices from the models placed in p
6each of the different crystal lattices and carried out
multicrystal density averaging, using a C-shell script to s
frun the CCP4 programs MAPROT for averaging densit-
ies, RSTATS for scaling calculated and observed struc- s
eture-factors, and FFT for map calculation (Collaborative
Computational Project, 1994; Stein et al., 1994). This s
oprocedure allowed us to monitor every step of the com-
putation. Six cycles of map averaging were usually s
tenough to ensure phase convergence. When phases
from a partial model containing only the outer domain
swere used, the Fo map showed discontinuous density
for the long α helix in the inner domain (Figure 5A in a
ogreen). With the same set of phases after multicrystal
averaging, the density for the α helix became more con- r
dtinuous and even showed some features for side
chains, indicating useful phase improvement (Figure 5A a
rin purple).
With many cycles of averaging, model rebuilding, and 2
tgradually expanding the averaging mask when neces-
sary, additional features emerged. The V4 variable loop, m
dprobably quite flexible in solution, makes crystal con-
tacts with its counterpart from a symmetry-related d
smolecule and appears ordered in the crystal. The den-ity for most glycans was tube-like before multicrystal
veraging, but in averaged maps a blob of density
ranched from the innermost N-acetyl glucosamine,
onsistent with reports that N-linked glycans on glyco-
roteins expressed in T ni. (Hi-5) cells are usually (α1-
) fucosylated at the protein-proximal N-acetyl gluco-
amine (Hsu et al., 1997). We assembled a library of
ucosylated N-linked glycans from high-resolution
tructures deposited in the PDB, for fitting into the
lectron density maps (Figure 5B). We found density for
ugars at all 13 glycosylation sites. A few glycans have
rdered saccharides even beyond the first branching
ite because of crystal contacts, while for others only
he first one or two sugars are visible.
In this manner, we located most of the inner domain
econdary-structure elements, including two α helices,
β sheet, and four glycans, as well as the four strands
f the bridging sheet, these last separated into two β-
ibbons. Three potential selenium sites not in the outer
omain had originally been identified from peaks in the
nomalous difference map. Two of these sites, sepa-
ated by just 6 Å, belong to the adjacent residues Met
55 and Met 256, in a one-turn α-helical configuration
hat connects inner and outer domains. Our current
odel does not account for the third SeMet anomalous
ifference peak, which could be a result of time-depen-
ent radiation decay (Ravelli and McSweeney, 2000) or
imply a consequence of poor isomorphous phases.
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203Figure 4. Fit of Part of the Outer Domain of
HIV gp120 to the Electron Density Map from
Experimental Phases
(A) Partial model of the outer domain from
HIV gp120 core structure fit to electron den-
sity map computed from experimental
phases after density modification. The long
α-helix and a surrounding β sheet of the
outer domain are shown as a ribbon diagram
in red, density for the helix in green, and
density for the sheet in blue.
(B) Plots of unsharpened and sharpened am-
plitudes and experimental figures of merit
(FOM) versus resolution. Experimental am-
plitudes and FOM fall off sharply with
increasing resolution, effectively reducing
the resolution of the electron density map in
(A) to 6.0 Å, despite inclusion of data to 4.0
Å resolution in the map calculation. Data
sharpening by a B factor of –200 was neces-
sary to reveal side chain density features.Model-based phases later yielded anomalous differ-
ence peaks corresponding to the remaining two SeMet
positions (see below). The V1-V2 stem (two of the
strands that form the bridging sheet) appeared disor-
dered until an averaged map was calculated at lower
resolutions (5.0, 5.5, or 6.0 Å). When the contour level
of these maps was set slightly lower than 1σ, density
in the most likely region for the V1-V2 stem became
apparent. The density matched the V1-V2 stem from
the HIV gp120 core model; the stem is clearly quite rigid
as a result of a disulfide bond at either end (Kwong et
al., 1998).
The low data-to-parameter ratio (the ratio of unique
X-ray reflections to the number of atoms in the model
is less than 2) influenced efforts to refine the model. We
carried out heavily restrained refinement calculations,
using both CNS and Refmac 5 (Brunger et al., 1998;
Murshudov, 1997). Main chain hydrogen-bond re-
straints and phi-, psi-restraints for helices were im-
posed in all CNS refinement runs, in order to prevent
stereochemical distortion. As a result, R and Rfree crystremained very similar. Harmonic restraints were also
imposed for the protein main chain and side chains and
for the glycans, varying the parameters so that outer
mannoses were held less tightly than inner N-acetyl
glucosamines. During model building, we used CNS to
improve model phases. After the model was complete,
two rounds of rebuilding based on the updated
averaged map were carried out without any refinement,
giving a model with Rfree close to 50%. Torsional simu-
lated annealing and minimization refinement in CNS,
using native data from 12.0 to 4.0 Å without bulk
solvent correction, brought the Rfree to 43%.
B-factor refinement in CNS failed, probably from al-
gorithmic instability due to insufficient experimental
data. (Note that B-factor refinement at 4.7 Å resolution
for p97 could succeed, because of noncrystallographic
symmetry; DeLaBarre and Brunger, 2003). We therefore
used TLS refinement as implemented in Refmac 5 to
derive a better temperature factor model. A single TLS
group was defined for the whole model, but analysis
with up to six groups (five inner-domain “domainlets”
Structure
204Figure 5. Phase Improvement by Multicrystal Averaging
(A) Flow chat for multicrystal averaging using CCP4 programs (Collaborative Computational Project, 1994).
(B) Phases from a model containing only part of the outer domain and experimental amplitudes were used to calculate an electron density
map with a mask including both inner and outer domains. The density for the long α helix in the inner domain is shown before multicrystal
averaging in green and after multicrystal averaging in purple. The density for Trp91 after averaging is as indicated. Both maps are contoured
at 1σ.
(C) Density after multicrystal averaging is shown for glycan 294. In the averaged maps, a blob of density buds out of the innermost N-acetyl
glucosamine residue, revealing the position of an α(1-6) fucosyl group.plus the outer domain) gave essentially the same re- R
ssults. TLS refinement, followed by limited minimization
with a flat bulk solvent model, yielded a model with sfree of 38.8% using native data from 26.0 to 4.0 Å. The
olvent model was optimized by changing probe and
hrink radii (the best values, 3.0 Å and 2.8 Å, respec-
SIV gp120 Envelope Glycoprotein
205tively, agree with those chosen during CNS refinement),
and the geometry was strongly restrained. Some details
of the TLS analysis are provided in Table 1. We further
validated the TLS results by carrying out B-domain re-
finement in CNS and in Refmac 5, using each of the
“domainlets” from the inner domain plus the outer do-
main as grouped structures (Supplemental Figure S1
available with this article online). The V1-V2 stem is
substantially more mobile than the other structural ele-
ments.
Model Validation
Heavy Atoms
Isomorphous difference maps with model-based
phases accurately return the positions of irridium and
lead atoms in the derivatives (Supplemental Table S1).
The TMLA sites are in hydrophobic pockets in the inner
domain. The principal IrCl62− site (Ir1 in Supplemental
Table S1) is adjacent to the second N-acetyl glucosam-
ine of the glycan attached to Asn 459, in a pocket
bounded both by sugars and by aromatic side chains
(Trp 344 of the polypeptide chain to which the glycan
belongs and Trp 342 and Tyr 428 of a crystallographi-
cally related chain). There are nearby positive charges
that might neutralize the negative charge on the IrCl62−
ion. The secondary IrCl62− site is likewise in a cavity
amidst N-acetyl glucosamines, with a nearby arginine
side chain. Thus, the heavy-atom sites, including the
TMLA positions in the inner domain, have the chemical
characteristics expected for the ligand they accom-
modate.
Selenium Positions
We calculated an anomalous difference map with
model-based phases, using only those anomalous dif-
ferences for which both amplitudes exceeded 2σ (Sup-
plemental Figure S2). Of the nine selenium sites (includ-
ing SeMet 65, introduced by the cloning strategy),
seven—SeMets 65 and 251 in the inner domain, SeM-
ets 265 and 266 in the connection between inner and
outer domains, and SeMets 308, 390, and 403 in the
outer domain—have strong corresponding peaks (Sup-
plemental Table S1). SeMets 356 and 481, opposite
each other in the hydrophobic core of the outer domain,
have weaker peaks, but they are clearly seen in residual
maps calculated during initial determination of Se loca-
tions, and they refine with reasonable occupancies
(Supplemental Table S1). Five of the nine SeMet sites,
including SeMet 65 and SeMet 251 that mark inner-do-
main elements, are included among the top twelve
peaks. Two of the remaining three peaks, SeMets 265
and 266 (unambiguously identified in the initial anoma-
lous difference map, Supplemental Table S1, and ro-
bustly refined in SHARP), may tend to cancel each
other at the approximately 5 Å resolution cutoff of the
difference map. Clarity of the model-based anomalous
difference map is probably limited by phase differences
between the slightly nonisomorphous SeMet and native
lattices (see Table 1) and by modest accuracy of the
SeMet diffraction data.
Comparison with Initial Experimental Map
Having built the inner domain, we looked back to com-
pare it with a map calculated using phases derived di-
rectly from isomorphous and anomalous differencesand hence completely unbiased by the model (Supple-
mental Figure S3, column A). The long helix, α1, the
sheet (β5, β7, β25), and the short helix (α5) of the inner
domain fit very well into the experimental density. The
position of SeMet 251, in the β5–β7 loop, further an-
chors the sheet. One of the two bridging-sheet ribbons
(β20–β21) has somewhat broken density. Only the other
bridging-sheet ribbon (β2–β3, the V1–V2 stem) is not
well represented in the experimental map.
Omit Maps
We calculated composite simulated-annealing omit
maps using CNS. Figure 6 shows that all the second-
ary-structure elements in the inner domain are well de-
fined, further confirming our general interpretation. Cer-
tain regions, mostly in loops, have weak density or
breaks in the composite map. For example, density is
discontinuous at the link in the inner domain between
the N terminus and α1, each of which lies in strong
density (Figure 6F). The N terminus is at a crystal con-
tact, and its position (with respect to the rest of the
protein) appears to vary among the crystal forms we
used for multicrystal averaging. Density for the glycan
at Asn71 supports our interpretation of the sequence
register for the N-terminal segment, as does the peak
for SeMet65, but at the current resolution, simulated
annealing composite omit maps are not powerful
enough to guide further rebuilding.
Overall Assessment of the Inner Domain Structure
The various validation steps just described provide
good evidence for placing each of the structural ele-
ments of the inner domain. The N-terminal segment
contains Met 65; helices α1 and α5 and the three-
strand sheet are clearly delineated by experimental
density; the loop between β5 and β7 contains Met 251;
the connection between β7 and the outer domain con-
tains Met 265 and Met 266; and the two ribbons of the
bridging sheet appear convincingly in various omit
maps. One of these ribbons, the V1-V2 stem, obviously
has greater disorder than any of the other structural
elements. It also has the highest group thermal param-
eter (Supplemental Figure S1).
Ordered Glycans
Figure 7 (A and B) summarizes the structures of N-linked
oligosaccharides that are ordered in the SIV gp120 core
structure. We could detect density for sugars at all 13
glycosylation sites, 7 of which were clearly (α1–6) fuco-
sylated. Eight glycans are ordered at least as far as the
first branch site. For glycan 459, four residues of one
branch were modeled as mannose with (α1–2) linkages,
but the identity of the last three residues, which make
contacts with a symmetry-related molecule, cannot be
determined at the current resolution. The long glycans
form apparent sugar clusters on the surface of the
molecule (Figure 7A). Cluster I includes glycan 277, 305,
and 459; of these, glycan 277 also contacts glycan 294
from a symmetry-related molecule, while glycan 459
participates in a crystal contact with polypeptide sur-
face. Cluster II contains glycans 243 and 246; the latter
also contacts its counterpart from a symmetry-related
molecule. Cluster III contains glycans 376, 475, and
478. Glycans 376 and 478 emerge from a concavity in
the gp120 surface of the protein and make several con-
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206Figure 6. Simulated Annealing Composite Omit Maps Contoured in the Vicinity of Each of the Secondary Structure Elements of the Inner
Domain
Maps were calculated using CNS (Brunger et al., 1998) for three different lattices and then averaged, using only one round (no rephasing) of
the protocol in Figure 5A. The elements shown in the figure are the hairpin from the outer domain (residues 436–457, A); the short helix and
C-terminus (residues 483–499, B); the long helix from the outer domain (residues 347–371, C); glycan 277 (D); the V1-V2 stem (residues 97–
219, E); the N terminus and the long helix from the inner domain (residues 64–97, F); the sheet from the inner domain (residues 229–268, G);
stick models are in yellow and density in blue. Maps are contoured at 1σ.tacts with amino-acid side chains. There are presuma- V
bly hydrogen bond networks within a sugar cluster, as c
well as bound waters. Therefore, both crystal contacts b
and interactions with other ordered glycans are likely a
to contribute to the detectability of particular oligosac- f
charides in the crystal structure. We note that the irid- 4
ium sites lie in glycan clusters. h
p
TCrystal Contacts
oThe uncertainty of the side chain conformations at the
ocurrent resolution makes it difficult to identify with cer-
Vtainty specific interactions, such as Van der Waals con-
4tacts, hydrogen bonds, and salt bridges, but there is no
mambiguity about which secondary structural elements
cand glycans contact symmetry-related molecules. The
most interesting contact is made by residues near the u4 loop, the base of the V3 loop and glycan 459. The
enter of this contact is a hydrophobic core, flanked
y hydrophilic interactions made by an oligosaccharide
nd by amino-acid side chains on both molecular sur-
aces. Near the base of V3, Trp 342, Trp 344, and Tyr
28 from one molecule (molecule I) apparently form a
ydrophobic patch, which interacts with the counter-
art from a symmetry-related molecule (molecule II).
he two branches of glycan 459 from molecule I extend
utward to contact both N- and C-terminal segments
f V4 from molecule II. The contact continues along the
4 loop, perhaps involving salt bridges between Glu
22 (I) and His 424 (II); it ends at Asn 417 (I), which
ay hydrogen bond with its symmetry mate (II). This
ontact, which was invariant in all three lattices we
sed for multicrystal averaging, creates a crystallo-
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207Figure 7. Structures of N-Linked Oligosac-
charides Visible in the Final Electron Den-
sity Map
Density for all 13 N-linked oligosaccharides
was found in the final electron density map.
(A) A view of SIV gp120 core structure in rib-
bon diagram showing that the long N-linked
glycans (stick model) form apparent sugar
clusters on the surface of the molecule.
Cluster I includes glycan 277, 305, and 459;
Cluster II, glycan 243 and 246; Cluster III,
glycan 376, 475, and 478.
(B) The structures are shown with ordered
residues in abbreviation as well as linkages;
GlcNAc, N-acetylglucosamine; Man, man-
nose; Fuc, fucose; Asn in bold shows the
glycosylated asparagine. Glycan 459 was
built as a high-mannose type, but the iden-
tity of the last three ordered residues of the
longer branch, which make contacts with a
symmetry-related molecule, is questionable
at current resolution.graphic dyad. The second major contact has on one
molecule the base of the hairpin that projects from the
outer domain to form part of the bridging sheet in the
CD4 bound conformation. On the opposite molecule
are the N terminus and part of the inner-domain loop
(residues 243 to 255). Two molecules (molecule III and
IV), related to each other by a crystallographic dyad,
pack against molecule I and II, respectively, through
this type of contact; they also make a further contact
with each other through a glycan:glycan interaction:
glycans 246 from the two molecules pack antiparallel
to each other. This molecule I–III contact varies among
the three lattices we used for averaging, and the den-
sity in this region is affected by the choice of the aver-
aging mask. Additional sugar-sugar interactions are
also observed between glycan 277 of molecule I and
glycan 294 of molecule IV. Thus, the overall crystalpacking involves protein-protein, protein-sugar, and
sugar-sugar contacts.
CD4 Binding Induces Major Rearrangements
in the gp120 Core
The gp120 of HIV and SIV are closely related. The sub-
stantial differences between the unliganded structure
described here and the liganded HIV gp120 studied by
Kwong et al. (1998) thus reflect primarily the effects of
CD4 binding. Figure 8 shows a Cα-trace superimposi-
tion of unliganded SIV gp120 core (red) and CD4 bound
HIV gp120 core (green). The two outer domains super-
pose well, except for some surface-exposed loops that
have different conformations due to deletions, inser-
tions or different positions of glycosylation sites. The
inner domain and bridging sheet, on the other hand,
rearrange drastically in response to CD4 binding. Sev-
Structure
208Figure 8. Comparison of Overall Structures of the Unliganded SIV gp120 and the CD4 Bound HIV gp120
A stereo view of superimposed Cα traces for unliganded SIV gp120 core (red) and CD4 bound HIV gp120 core (green). The outer domains of
the two proteins, highlighted in dark colors, have essentially the same fold; the inner domains and bridging-sheet elements, in light colors,
are markedly different.eral of the inner-domain secondary-structure elements b
bmove independently, rather than in a coordinated fash-
ion. That is, the “inner domain” is not a single, coherent t
lfolded structure, but rather a set of distinct structural
elements that rearrange with respect to each other. A
adetailed discussion of the CD4-induced conformational
changes will be published elsewhere (Chen et al., in c
ppress).
c
tDiscussion
c
pGlycoproteins with a modest degree of glycosylation
often crystallize readily. For example, a number of vari- t
mants of influenza haemagglutinin (HA), with 5 to 6 gly-
cans per 60 kDa of protein, have yielded relatively high- p
presolution structures (Gamblin et al., 2004; Stevens et
al., 2004; Wilson et al., 1981). Crystallization can some- r
ftimes be impeded, however, by the heterogeneity of
glycosylation and the conformational flexibility of car- c
tbohydrates. Influenza HA lacks sialic acid, a major
source of charge heterogeneity in many glycoproteins p
2from mammalian cells, perhaps contributing to its ease
of crystallization. Deglycosylation was essential for ob- p
ptaining crystals of HIV gp120 core protein suitable for
structural studies (Kwong et al., 1999). We were there- l
cfore surprised to find that the fully glycosylated SIV
gp120 core protein crystallized with 13 N-linked oligo- i
bsaccharides, when strategies such as deglycosylation
or decoration with Fabs had failed. One striking feature g
tof the structure is the extent to which the oligosaccha-
rides form clusters on the protein surface. It is likely o
tthat there are extended hydrogen bonding networks
within these clusters, perhaps imposing some con- p
bstraints on the conformation of distal residues in a
given glycan. High-resolution data, absent in the cur- t
prent work, would be required to identify such interac-
tions. We note that glycans 70, 211, and 370, which lie
poutside any of the clusters, have only one or two or-
dered sugars, consistent with the notion that hydrogen aonding among sugars may limit conformational flexi-
ility. Moreover, some of the glycans participate in crys-
al contacts, which also appear to be a source of stabi-
ization.
A number of crystal structures have been determined
t about 4 Å resolution: examples include the reovirus
ore (Reinisch et al., 2000), the CD4-MHC class II com-
lex (Wang et al., 2001), the anthrax toxin/receptor
omplex (Lacy et al., 2004), and the AP1 clathrin adap-
or complex (Heldwein et al., 2004). In most of these
ases, relatively accurate phases from molecular re-
lacement and high order noncrystallographic symme-
ry helped in obtaining an interpretable electron density
ap for model building. Despite the low data-to-
arameter ratio, refinement of the resulting models was
ossible when NCS constraints and strong geometrical
estraints were imposed. Brunger and colleagues re-
ined the structure of p97/valosin-containing protein
omplex with data to only 4.7 Å, aided by a combina-
ion of selenomethionine MAD phasing, molecular re-
lacement, and 3-fold NCS (DeLaBarre and Brunger,
003). In the case of the SIV gp120 core, the initial
hases were not very accurate because of the poor
hasing power of the heavy atom derivatives and the
arge differences between the CD4 bound HIV gp120
ore and the unliganded SIV gp120 core. Indeed, we
nitially failed to appreciate the structural differences
ecause of the unexpectedly large number of ordered
lycans in our crystals. Moreover, the lack of NCS and
he modest solvent content (60%) reduced the power
f phase improvement by density modification. None-
heless, positions of Se atoms in SeMet substituted
rotein, locations of ordered glycans, use of the CD4
ound HIV gp120 core model as a guide, and multicrys-
al averaging together enabled us to improve the
hases and extend the model gradually.
Refinement was difficult because of a low data-to-
arameter ratio. The structure of the AP-1 clathrin
daptor complex, which was built from a far better
SIV gp120 Envelope Glycoprotein
209map, refined with data to 4 Å only when 6-fold NCS
constraints were included in refinement (Heldwein et
al., 2004; K.E.H. and S.C.H., unpublished data). It would
have been possible in principle to refine the SIV gp120
core structure simultaneously against the three inde-
pendent data sets from three lattices (Bc44n, Hbc7 and
Hbc2/3), to increase the ratio of observations to param-
eters, but the appropriate refinement algorithm has not
yet been implemented. We therefore chose to proceed
with refinement against our best native data set by im-
posing restraints whenever possible, including main
chain hydrogen bond restraints and phi-, psi-restraints
for helices as well as harmonic restraints for all the gly-
cans. It is useful to set a gradient of harmonic restraints
along a glycan with the highest level of restraint as-
signed to the innermost N-acetyl glucosamine and the
lowest to the outermost mannose based on the as-
sumption that distal residues of a given glycan are more
mobile than proximal residues. There are exceptions to
this assumption–for instance, the distal mannoses of
glycan 459 may be fixed by crystal contacts. Refine-
ment against data set Cbc4, which includes data to 3.9
Å, did not yield better results, probably because of in-
completeness and anisotropy of the data. Refining the
model against both native data and Cbc4 indepen-
dently helped resolve ambiguities in side chain confor-
mations at later stages of model building.
Efforts to push the resolution of our data beyond the
water ring (3.8 Å) will be required to resolve ambiguities
and imprecisions in the model. Nonetheless, the model
at the current resolution clearly reveals the large re-
arrangement of the inner domain of gp120 core upon
CD4 binding. It is likely to shape our thinking about the
organization of the trimeric gp120/gp41 complex on the
surface of the virion. We expect that it may also influ-
ence strategies for antiviral-drug and AIDS vaccine
design.
Experimental Procedures
Protein Production and Crystallization
pSIVgp120core (for definition, see Figure 1) was constructed by
standard PCR techniques. We deleted residues from the N- and C
termini of SIV gp120, as in Kwong et al. (1999), and we substituted
short linkers for the V1-V2 and V3 loops. Two additional residues
(His-Met) were introduced by the restriction site (Nde I) at the N
terminus. Both restriction digestion and DNA sequencing verified
the expression construct. The proteins were expressed using the
Bac-to-Bac system (Invitrogen) following a procedure described
previously (Chen et al., 2000). Briefly, recombinant baculovirus was
generated according to the manufacturer’s protocol and amplified
in Sf9 insect cells in Hink’s TNM-FH medium (JRH Biosciences).
The optimal amount of virus and postinfection harvest time were
determined by small-scale tests in 100 ml spinner flasks. For large-
scale protein production, 12 liter of T. ni (Hi-5) cells (2 × 106 cells/
ml) in Ex-cell 405 medium (JRH Biosciences) were infected at an
MOI of 2.5. The supernatant was harvested 72 hr postinfection by
centrifugation and concentrated to 1 liter in a tangential flow filtra-
tion system, ProFlux M 12 (Millipore). The concentrated superna-
tant was clarified by centrifugation.
Expressed SIV gp120 core protein was purified by immunoaffinity
chromatography with mAb 17A11 (Edinger et al., 2000; Chen et al.,
2000). The concentrated insect cell supernatants were passed
through the column at 0.5 ml/min. After extensive washing with
PBS, protein was eluted with 100 mM glycine (pH 2.5) and immedi-
ately neutralized by 2 M Tris (pH 8.0). Fractions were analyzed by
SDS-PAGE. Those containing SIV gp120 core protein were pooled,concentrated, and further purified by gel filtration chromatography
on Superdex 200 (Pharmacia) with a buffer containing 25 mM Tris-
HCl (pH 8.0) and 150 mM NaCl. The protein was concentrated to
30 O.D.280/ml, frozen in liquid nitrogen and stored at –80°C. The
expected N terminus of the SIV gp120 core protein was confirmed
by N-terminal sequencing.
SeMet-substituted SIV gp120 core protein was produced
following a published procedure (Carfi et al., 2001). Briefly, 6 L of T.
ni cells (2 × 106 cells/ml) were infected at an MOI of 2.5. Starvation
was initiated by gently spinning the cells (600 g, 5 min) 24 hr postin-
fection and resuspending them into customized Ex-cell 405 me-
dium from which methionine was omitted (JRH Biosciences). After
starvation for 7 hr, the cells were spun and resuspended in custo-
mized Ex-cell 405 medium supplemented with 75 mg/L seleno-
methionine (Sigma) and 5% FBS (Sigma). The supernatant was har-
vested 72 hr postinfection by centrifugation and concentrated to
0.5 L. SeMet-substituted protein was then purified and stored as
described above.
Crystals were grown in hanging drops. The protein was mixed,
at 1:1 ratio, with mother liquor containing 15% PEG 6000, 100 mM
sodium citrate, (pH 5.0) and 8% PEG 400 at 20°C. Crystals ap-
peared in a few days and grew to about 100 microns in the largest
dimension in 2–3 weeks. Crystals were briefly soaked in mother
liquor before transfer to a solution containing 17% PEG 6000, 100
mM sodium citrate, 8% PEG 400 and 15% sucrose, and flash-freez-
ing in liquid nitrogen. Smaller crystals (about 70 microns) were ob-
tained with SeMet-substituted SIV gp120 core protein under the
same conditions. Amino acid analysis of the SeMet-substituted
protein showed an incorporation rate of at least 50%. To make
heavy atom derivatives, over 60 heavy atom compounds were dis-
solved in soaking solution containing 15% PEG 6000, 100 mM so-
dium citrate, (pH 5.0) and 8% PEG 400. The final concentration was
adjusted to 1 mM when possible, and a saturated solution was
used if the compound was not soluble at 1 mM. Soaks were al-
lowed to proceed for 24 hr at 20°C.
Data Collection and Phase Improvement
Data were collected with 0.5 or 1º oscillation and an exposure time
of 3 min per frame at CHESS F1, or 5 s per frame at APS 19ID
(where no beam attenuation was used). To use synchrotron beam-
time more efficiently, crystals soaked with heavy atom compounds
were screened by collecting a 20-frame “mini data set,” which was
scaled to the native data set. Complete data were collected only
for derivatives that showed promising statistics after mini data set
scaling. Data were also collected for K2IrCl6 soaked crystals in an
inverse beam mode at beamline F1 to maximize anomalous signal
(Ibc1 in Table1), or with larger beam stop-to-crystal distance to
include low-resolution reflections (Sbc10L in Table 1). A single-
wavelength (peak) data set from SeMet crystals, collected at APS
19ID, extended to about 5 Å; data collected at other wavelengths
(inflection and remote) were not useful because of deterioration
from radiation damage. Denzo and Scalepack or HKL2000 were
used for data processing (Otwinowski and Minor, 1997). Molecular
replacement was performed using the program AMORE (Navaza
and Saludjian, 1997)
Subsequent phase improvement by iterative cycles of phase
combination (partial model phases and experimental phases), den-
sity modification, and data sharpening were performed using the
CCP4 programs SIGMAA, DM, and CAD (Collaborative Computa-
tional Project, 1994). Initially, data were sharpened by applying a
B-factor of –200 to the amplitudes in order to show side chain den-
sity. With improvement of the model phases, the sharpening
B-factor could be reduced to –100. Transformation matrices relat-
ing model positions in three different crystal lattices—native
(Bc44n), IrCl3-soaked (Hbc7), and CdI-soaked (Hbc2/3) crystals—
were determined from both rigid-body refinement using CNS and
molecular replacement using AMORE. Multicrystal averaging was
then performed using a C-shell script to run the CCP4 programs
MAPROT for map averaging, RSTATS for data scaling, and FFT for
map calculation (Figure 5).
Model Building and Refinement
Program O was used for model building (Jones et al., 1991) and
both CNS (Brunger et al., 1998) and Refmac 5 (Murshudov, 1997),
Structure
210for heavily restrained refinement. Torsional simulated annealing and b
vminimization in CNS were carried out initially with the phase-
restrained MLHL target and later with the MLF target. TLS refine- C
ment, followed by limited minimization with a flat bulk solvent r
model, was performed with Refmac 5, as described in the main c
text. The final model contains all residues in the gp120 core, plus
C
the vector-derived His64 and Met65, with the exception of residues
p
220–228 and 500–502.
t
D
GSupplemental Data
eSupplemental data include three figures and one table and can be
3found with this article online at http://www.structure.org/cgi/content/
dfull/13/2/197/DC1/.
h
pAccession Numbers
M
The coordinates have been deposited in the Protein Data Bank for D
accession number 2BF1. v
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